What Happened?
, -based Appia Bio Appointed Sylvaine Cases as Chief Business Officer
Date of management change: June 28, 2023
, -based Appia Bio Appointed Sylvaine Cases as Chief Business Officer
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Sylvaine Cases is Chief Business Officer at Appia Bio. Previously, Sylvaine held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Hall LaShawnda, Serpente Anne, Bishop Timothy, Rawls Nadia, Goldstein Ivy, Hanson Kira, Hooyman Trudy, Sproul Tisa, Johnson-Davis Yolanda, Clark Kyra, Kaiser John
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.